Vaxart, Inc. (VXRT)
NASDAQ: VXRT · Real-Time Price · USD
0.4196
+0.0126 (3.10%)
At close: May 9, 2025, 4:00 PM
0.4000
-0.0196 (-4.67%)
After-hours: May 9, 2025, 7:56 PM EDT
Vaxart Employees
Vaxart had 105 employees as of December 31, 2024. The number of employees decreased by 4 or -3.67% compared to the previous year.
Employees
105
Change (1Y)
-4
Growth (1Y)
-3.67%
Revenue / Employee
$273,333
Profits / Employee
-$637,600
Market Cap
95.65M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
VXRT News
- 4 days ago - Vaxart CEO Issues Letter to Stockholders Highlighting Company Progress - GlobeNewsWire
- 7 days ago - Vaxart to Host First Quarter 2025 Business Update and Financial Results Conference Call on May 13 - GlobeNewsWire
- 9 days ago - Vaxart Completes Enrollment in Phase 1 Trial for its Norovirus Oral Pill Vaccine Candidate - GlobeNewsWire
- 23 days ago - Vaxart to Present at World Vaccine Congress Washington 2025 on April 23 - GlobeNewsWire
- 23 days ago - Vaxartto Present at World Vaccine Congress Washington 2025 on April 23 - GlobeNewsWire
- 6 weeks ago - Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - Vaxart, Inc. (VXRT) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Vaxart Provides Business Update and Reports Full Year 2024 Financial Results - GlobeNewsWire